At $1.35 I added more shares. Just for a quick trade, any move up above 1.45 and it's sell. Chip the new CEO will made a deal soon on the stem cells, I hope.
Good luck in this rigged casino,
Wednesday, December 21, 2011
Friday, December 16, 2011
Geron volume 5 million today
Volume was 5,494,100 today the avg ten day volume is 1,101,076 shares. Why the big increase on Friday. I checked the message board and no one knows. Alot of guesses.
The share price is worrying me. It could go below a dollar. Waiting for a parnter. Good news from the four Phase II trials will raise the share price. If by the end of 2012 the results from the 4 Phase II trials are anything but outstanding, I will sell most of my shares. For now any move over $2, I will sell some shares and sell a few covered calls.
I put a lot of time and money into Geron, believing [and still do] in the stem cell program, now there is very little reason for me to hold a large position in this company. Will cut my position by at least half.
Good luck in this rigged casino,
The share price is worrying me. It could go below a dollar. Waiting for a parnter. Good news from the four Phase II trials will raise the share price. If by the end of 2012 the results from the 4 Phase II trials are anything but outstanding, I will sell most of my shares. For now any move over $2, I will sell some shares and sell a few covered calls.
I put a lot of time and money into Geron, believing [and still do] in the stem cell program, now there is very little reason for me to hold a large position in this company. Will cut my position by at least half.
Good luck in this rigged casino,
Wednesday, December 14, 2011
Geron Patient #5 Katie Sharify
Stem cell trial halted, but 23-year-old recipient still has hope
http://www.mercurynews.com/bay-area-news...
Stem cell clinical trials were still under way last month when Katie Sharify's car careened off Highway 5, ejecting her through the back window and paralyzing her from the waist down.
Stanford and Valley Medical Center doctors considered Sharify an ideal candidate to test whether an injection of embryonic cells was safe and could help her regain any sensation.
But just two days before she was scheduled to receive the treatment, the Menlo Park company leading the trials canceled the program. Sharify's doctors injected her anyway, giving her a chance, no matter how small, that two million stem cells creeping up her damaged spine could make a difference.On Tuesday, as Sharify, 23, sat in her wheelchair at Santa Clara County's Valley Medical Center, she discussed her mixed feelings about being the fifth -- and for now, the last -- patient in the United States to receive the experimental treatment for paralysis victims.
Words come easily to Sharify; she had been a communications major at USC and a 2006 graduate of Amador Valley High School in Pleasanton, where she had been a member of a future business leaders club.
"I want someone somewhere to see me," Sharify said. "Maybe there's a head of a big company who sees this and says, 'we should help this girl.' "
Good luck in this rigged casino,
http://www.mercurynews.com/bay-area-news...
Stem cell clinical trials were still under way last month when Katie Sharify's car careened off Highway 5, ejecting her through the back window and paralyzing her from the waist down.
Stanford and Valley Medical Center doctors considered Sharify an ideal candidate to test whether an injection of embryonic cells was safe and could help her regain any sensation.
But just two days before she was scheduled to receive the treatment, the Menlo Park company leading the trials canceled the program. Sharify's doctors injected her anyway, giving her a chance, no matter how small, that two million stem cells creeping up her damaged spine could make a difference.On Tuesday, as Sharify, 23, sat in her wheelchair at Santa Clara County's Valley Medical Center, she discussed her mixed feelings about being the fifth -- and for now, the last -- patient in the United States to receive the experimental treatment for paralysis victims.
Words come easily to Sharify; she had been a communications major at USC and a 2006 graduate of Amador Valley High School in Pleasanton, where she had been a member of a future business leaders club.
"I want someone somewhere to see me," Sharify said. "Maybe there's a head of a big company who sees this and says, 'we should help this girl.' "
Good luck in this rigged casino,
Monday, December 12, 2011
Geron Initiates Phase 2 of GRN1005 in Brain Metastases From Breast Cancer
Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer
Great news! If Geron can get good results, it will be fast tracked. In patients with brain metastases from solid tumors, overall response rate was 20% (4/20) by one dimensional assessment when treated with a dose of 650 mg/m(2) of GRN1005 administered as single-agent therapy once every three weeks.
Good luck in this rigged casino,
Great news! If Geron can get good results, it will be fast tracked. In patients with brain metastases from solid tumors, overall response rate was 20% (4/20) by one dimensional assessment when treated with a dose of 650 mg/m(2) of GRN1005 administered as single-agent therapy once every three weeks.
Good luck in this rigged casino,
Sunday, December 11, 2011
No news for Geron
Geron volume was only 814,240 shares over five days. Ten day avg. volume was 1,042,103 and three months was 1,517,420 shares. The high for the week was $1.77 on Monday the low $1.55 on Thursday.
Need partners.
Celgene, Pfizer and Teva Pharm. are in stem cell research, small time. Partnering with Geron would make them big time and they have the money to fund the research.
The share price is worrying me. It could go below a dollar. Waiting for a parnter. Good news from the four Phase II trials will raise the share price. If by the end of 2012 the results from the 4 Phase II trials are anything but outstanding, I will sell most of my shares. For now any move over $2, I will sell some shares and sell a few covered calls.
I put a lot of time and money into Geron, believing [and still do] in the stem cell program, now there is very little reason for me to hold a large position in this company. Will cut my position by at least half.
Good luck in this rigged casino,
Need partners.
Celgene, Pfizer and Teva Pharm. are in stem cell research, small time. Partnering with Geron would make them big time and they have the money to fund the research.
The share price is worrying me. It could go below a dollar. Waiting for a parnter. Good news from the four Phase II trials will raise the share price. If by the end of 2012 the results from the 4 Phase II trials are anything but outstanding, I will sell most of my shares. For now any move over $2, I will sell some shares and sell a few covered calls.
I put a lot of time and money into Geron, believing [and still do] in the stem cell program, now there is very little reason for me to hold a large position in this company. Will cut my position by at least half.
Good luck in this rigged casino,
Tuesday, December 6, 2011
No news is the story for Geron
No news on the patent case against Viacyte. No news on anyone buying Geron's stem cell program. No news on partnering. No increase in volume or share price.
Just wait and see if "Chip" the new CEO can work some magic.
Good luck in this rigged casino,
Just wait and see if "Chip" the new CEO can work some magic.
Good luck in this rigged casino,
Thursday, December 1, 2011
Geron slowly moving up, why
The patent case against Viacyte is coming to a end. We should have an announcement Thursday or early next week. Hoping it's good news for longs. Geron share price is $1.76 up 9 cent. at 1:36PM.
Good luck in this riggeed casino,
Good luck in this riggeed casino,
Subscribe to:
Posts (Atom)